(Q45174420)

10 December 2017

title

Endothelin-mediated remodeling in aortas of diabetic rats (English)

1 reference

10 December 2017

2

1 reference

10 December 2017

Gen Fukuda

1

1 reference

10 December 2017

Yousef P Barbin

3

1 reference

10 December 2017

Hana Farhangkhoee

4

1 reference

10 December 2017

Ronald G Tilton

5

1 reference

10 December 2017

Subrata Chakrabarti

6

1 reference

10 December 2017

publication date

1 July 2005

1 reference

Diabetes - Metabolism: Research and Reviews

10 December 2017

published in

1 reference

10 December 2017

volume

21

1 reference

10 December 2017

issue

4

1 reference

10 December 2017

page(s)

367-375

1 reference

High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1.

10 December 2017

cites work

1 reference

A family of fibronectin mRNAs in human normal and transformed cells

21 January 2018

1 reference

Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis

21 January 2018

1 reference

Determination of membrane thickness distribution from orthogonal intercepts

21 January 2018

1 reference

Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications

21 January 2018

1 reference

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

21 January 2018

1 reference

7 January 2021

Hyperhexosemia induced functional and structural changes in the kidneys: role of endothelins

1 reference

7 January 2021

Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors

1 reference

7 January 2021

Diabetes-induced vascular dysfunction in the retina: role of endothelins

1 reference

7 January 2021

Endothelin receptor blockade prevents augmented extracellular matrix component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose-fed rats

1 reference

7 January 2021

Effect of a specific endothelin receptor A antagonist on mRNA levels for extracellular matrix components and growth factors in diabetic glomeruli

1 reference

7 January 2021

Cell surface interactions with extracellular materials

1 reference

7 January 2021

Transforming growth factor beta in tissue fibrosis

1 reference

7 January 2021

Reversibility of glucose-induced changes in mesangial cell extracellular matrix depends on the genetic background

1 reference

7 January 2021

Angiotensin converting enzyme inhibition reduces the expression of transforming growth factor-beta1 and type IV collagen in diabetic vasculopathy

1 reference

7 January 2021

The angiogenesis marker ED-B+ fibronectin isoform in intracranial meningiomas

1 reference

7 January 2021

Oncofetal fibronectin in diabetic retinopathy.

1 reference

7 January 2021

Angiotensin II enhances glomerular expression of a nonmuscle myosin heavy chain, SMemb, with extracellular matrix accumulation

1 reference

7 January 2021

Phenotypic modulation of the mesangium reflected by contractile proteins in diabetes

1 reference

7 January 2021

Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist

1 reference

7 January 2021

Acyl substitution at the ortho position of anilides enhances oral bioavailability of thiophene sulfonamides: TBC3214, an ETA selective endothelin antagonist

1 reference

7 January 2021

Contributions of endothelin-1 and sodium hydrogen exchanger-1 in the diabetic myocardium.

1 reference

7 January 2021

Effects of diabetes and hypoxia on gene markers of angiogenesis (HGF, cMET, uPA and uPAR, TGF-alpha, TGF-beta, bFGF and Vimentin) in cultured and transplanted rat islets

1 reference

7 January 2021

Nonmuscle and smooth muscle myosin heavy chain expression in rejected cardiac allografts. A study in rat and monkey models

1 reference

7 January 2021

Diabetes-induced vascular hypertrophy is accompanied by activation of Na(+)-H(+) exchange and prevented by Na(+)-H(+) exchange inhibition

1 reference

7 January 2021

Production of endothelin-1 from the mesenteric arteries of streptozotocin-induced diabetic rats

1 reference

7 January 2021

Alteration of endothelins: a common pathogenetic mechanism in chronic diabetic complications.

1 reference

7 January 2021

Angiotensin II increases tissue endothelin and induces vascular hypertrophy: reversal by ET(A)-receptor antagonist

1 reference

7 January 2021

Angiotensin II induces human TGF-beta 1 promoter activation: similarity to hyperglycaemia

1 reference

7 January 2021

The Renin-Angiotensin System in Diabetic Nephropathy: The Endothelial Connection

1 reference

7 January 2021

Diabetes-associated mesenteric vascular hypertrophy is attenuated by angiotensin-converting enzyme inhibition

1 reference

7 January 2021

Angiotensin converting enzyme inhibition and calcium antagonism attenuate streptozotocin-diabetes-associated mesenteric vascular hypertrophy independently of their hypotensive action

1 reference

7 January 2021

Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

1 reference

7 January 2021

A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression

1 reference

7 January 2021

Orally active endothelin receptor antagonist BMS-182874 suppresses neointimal development in balloon-injured rat carotid arteries

1 reference

7 January 2021

Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis

1 reference

7 January 2021

Inhibition of myocardial endothelin pathway improves long-term survival in heart failure

1 reference

7 January 2021

Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction

1 reference

7 January 2021

Hyperglycemia-induced alteration of vascular smooth muscle phenotype

1 reference

7 January 2021

Identifiers

DOI

10.1002/DMRR.527

1 reference

10 December 2017

1 reference